~18 spots leftby Apr 2026

Dietary Changes for Psoriatic Arthritis

(DIPSA Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
AO
LE
Overseen byLihi Eder, MD, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Pennsylvania
No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to learn whether changing diet impacts psoriatic arthritis (PsA).

Research Team

AO

Alexis Ogdie-Beatty, MD, MSCE

Principal Investigator

University of Pennsylvania

LE

Lihi Eder, MD, PhD

Principal Investigator

Women's College Hospital, University of Toronto

Eligibility Criteria

This trial is for adults aged 18-80 with a BMI between 25 and 40, diagnosed with Psoriatic Arthritis by a rheumatologist. Participants must have been on stable PsA treatment for at least three months, own a smartphone or be willing to use one provided, and are open to changing their diet for the study duration. Exclusions include eating disorders, certain medical conditions like insulin-dependent diabetes or advanced cancer, food allergies related to the study diets, inability to consent or read/write in English.

Inclusion Criteria

My Psoriatic Arthritis diagnosis is confirmed by a rheumatologist.
No history of eating disorders such as anorexia or bulimia
Owns and uses an iPhone or Android smart phone, or is willing to use a device provided by the study team
See 6 more

Exclusion Criteria

I am currently taking corticosteroids.
Inability to read and write in English
You are pregnant or could become pregnant.
See 6 more

Treatment Details

Interventions

  • Diet 1 (N/A)
  • Diet 2 (N/A)
Trial OverviewThe trial is testing two different diets' effects on psoriatic arthritis over a period of 24 weeks. Patients will be assigned one of these diets and will need to adhere strictly while attending regular follow-up visits. The goal is to see if dietary changes can improve symptoms associated with PsA.
Participant Groups
3Treatment groups
Active Control
Group I: Diet 1Active Control1 Intervention
Diet 1 will focus on the dietary pattern and monitor types of foods, supplementary nutrition, and provide nutritional support with a dietitian.
Group II: Diet 2Active Control1 Intervention
Diet 2 will focus on the dietary pattern and monitor the amount of food, complimentary nutrition, and nutritional support with a dietitian.
Group III: Diet 3Active Control1 Intervention
Diet 3 will focus on healthy dietary patterns and provide nutritional support with a dietitian.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+
Dr. Joan Lau profile image

Dr. Joan Lau

University of Pennsylvania

Chief Executive Officer since 2020

PhD in Neuroscience from the University of Cincinnati College of Medicine, MBA from the Wharton School of Business, BS in Bioengineering from the University of Pennsylvania

Dr. Robert Iannone profile image

Dr. Robert Iannone

University of Pennsylvania

Chief Medical Officer since 2019

MD from Yale University, MSCE from the University of Pennsylvania

Women's College Hospital

Collaborator

Trials
108
Recruited
43,700+

Heather McPherson

Women's College Hospital

Chief Executive Officer since 2020

Master of Science in Rehabilitation Science, University of Toronto

Dr. Cindy Maxwell

Women's College Hospital

Chief Medical Officer since 2023

MD, specialization in Maternal Fetal Medicine

NYU Langone Health

Collaborator

Trials
1,431
Recruited
838,000+
Dr. Alec C. Kimmelman profile image

Dr. Alec C. Kimmelman

NYU Langone Health

Chief Executive Officer

MD and PhD from Mount Sinai School of Medicine

Dr. Nicole M. Adler profile image

Dr. Nicole M. Adler

NYU Langone Health

Chief Medical Officer since 2023

MD